top of page
dropper cell pebble life sciences cancer treatment.jpg


Interim prototype targeted platinum resistant ovarian cancer

Building from Pebble’s anti-inflammatory hypothesis and MD Anderson preclinical results, our optimized prototype achieved ongoing CA-125 stabilization and maintained absolute lymphocyte values, continuing through first two cycles of immunosuppressant Elahere.

Screenshot 2024-04-10 at 3.04.04 PM.png
bottom of page